AstraZeneca Plc shares rose after trial data showed Tagrisso slowed disease progression in patients with advanced lung cancer in another win for the pharmaceutical giant’s blockbuster drug.
AstraZeneca Rises as Key Lung Cancer Drug Scores Another Win
Posted in biotech/medical